NCT02883361 2024-12-05
MI for AIs
University of Calgary
Phase 2/3 Withdrawn
Clinical Trials
4 trialsNCT00397761 2021-02-17
Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer
Medstar Health Research Institute
Phase 2/3 Withdrawn
NCT01724242 2017-11-28
Vaginal DHEA for Women After Breast Cancer
Hadassah Medical Organization
Phase 2/3 Withdrawn
NCT02651610 2017-07-11
Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer
Peregrine Pharmaceuticals
Phase 2/3 Withdrawn